Logo image of EXPO

EXPONENT INC (EXPO) Stock Fundamental Analysis

NASDAQ:EXPO - US30214U1025 - Common Stock

72.29 USD
+1.81 (+2.57%)
Last: 8/22/2025, 8:05:29 PM
72.29 USD
0 (0%)
After Hours: 8/22/2025, 8:05:29 PM
Fundamental Rating

6

Overall EXPO gets a fundamental rating of 6 out of 10. We evaluated EXPO against 81 industry peers in the Professional Services industry. EXPO scores excellent points on both the profitability and health parts. This is a solid base for a good stock. EXPO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

EXPO had positive earnings in the past year.
In the past year EXPO had a positive cash flow from operations.
EXPO had positive earnings in each of the past 5 years.
Each year in the past 5 years EXPO had a positive operating cash flow.
EXPO Yearly Net Income VS EBIT VS OCF VS FCFEXPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

1.2 Ratios

The Return On Assets of EXPO (13.54%) is better than 91.36% of its industry peers.
EXPO has a better Return On Equity (24.04%) than 79.01% of its industry peers.
The Return On Invested Capital of EXPO (13.57%) is better than 77.78% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EXPO is significantly above the industry average of 12.68%.
The last Return On Invested Capital (13.57%) for EXPO is well below the 3 year average (18.56%), which needs to be investigated, but indicates that EXPO had better years and this may not be a problem.
Industry RankSector Rank
ROA 13.54%
ROE 24.04%
ROIC 13.57%
ROA(3y)15.66%
ROA(5y)15.2%
ROE(3y)28.66%
ROE(5y)26.61%
ROIC(3y)18.56%
ROIC(5y)16.83%
EXPO Yearly ROA, ROE, ROICEXPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

EXPO has a better Profit Margin (18.35%) than 88.89% of its industry peers.
EXPO's Profit Margin has been stable in the last couple of years.
With an excellent Operating Margin value of 20.46%, EXPO belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
In the last couple of years the Operating Margin of EXPO has remained more or less at the same level.
EXPO has a better Gross Margin (92.62%) than 98.77% of its industry peers.
EXPO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.46%
PM (TTM) 18.35%
GM 92.62%
OM growth 3Y-2.87%
OM growth 5Y0.97%
PM growth 3Y-3.48%
PM growth 5Y-0.25%
GM growth 3Y-0.15%
GM growth 5Y-0.21%
EXPO Yearly Profit, Operating, Gross MarginsEXPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

9

2. Health

2.1 Basic Checks

EXPO has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for EXPO has been increased compared to 1 year ago.
EXPO has less shares outstanding than it did 5 years ago.
EXPO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EXPO Yearly Shares OutstandingEXPO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
EXPO Yearly Total Debt VS Total AssetsEXPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 9.49 indicates that EXPO is not in any danger for bankruptcy at the moment.
The Altman-Z score of EXPO (9.49) is better than 96.30% of its industry peers.
EXPO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.49
ROIC/WACC1.53
WACC8.9%
EXPO Yearly LT Debt VS Equity VS FCFEXPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 3.15 indicates that EXPO has no problem at all paying its short term obligations.
EXPO has a Current ratio of 3.15. This is amongst the best in the industry. EXPO outperforms 86.42% of its industry peers.
EXPO has a Quick Ratio of 3.15. This indicates that EXPO is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of EXPO (3.15) is better than 87.65% of its industry peers.
Industry RankSector Rank
Current Ratio 3.15
Quick Ratio 3.15
EXPO Yearly Current Assets VS Current LiabilitesEXPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

EXPO shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.44%.
EXPO shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.74% yearly.
Looking at the last year, EXPO shows a small growth in Revenue. The Revenue has grown by 3.47% in the last year.
EXPO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.01% yearly.
EPS 1Y (TTM)-2.44%
EPS 3Y3.72%
EPS 5Y6.74%
EPS Q2Q%-8.77%
Revenue 1Y (TTM)3.47%
Revenue growth 3Y6.2%
Revenue growth 5Y6.01%
Sales Q2Q%0.33%

3.2 Future

Based on estimates for the next years, EXPO will show a small growth in Earnings Per Share. The EPS will grow by 3.43% on average per year.
EXPO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.51% yearly.
EPS Next Y-4.74%
EPS Next 2Y1.79%
EPS Next 3Y3.43%
EPS Next 5YN/A
Revenue Next Year3.1%
Revenue Next 2Y5.27%
Revenue Next 3Y5.51%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
EXPO Yearly Revenue VS EstimatesEXPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
EXPO Yearly EPS VS EstimatesEXPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 36.15 indicates a quite expensive valuation of EXPO.
Based on the Price/Earnings ratio, EXPO is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
EXPO's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.24.
The Price/Forward Earnings ratio is 32.91, which means the current valuation is very expensive for EXPO.
Based on the Price/Forward Earnings ratio, EXPO is valued a bit more expensive than 62.96% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of EXPO to the average of the S&P500 Index (22.81), we can say EXPO is valued slightly more expensively.
Industry RankSector Rank
PE 36.15
Fwd PE 32.91
EXPO Price Earnings VS Forward Price EarningsEXPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

EXPO's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. EXPO is more expensive than 67.90% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as EXPO.
Industry RankSector Rank
P/FCF 30.19
EV/EBITDA 27.44
EXPO Per share dataEXPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The excellent profitability rating of EXPO may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)5.36
EPS Next 2Y1.79%
EPS Next 3Y3.43%

6

5. Dividend

5.1 Amount

EXPO has a Yearly Dividend Yield of 1.70%.
EXPO's Dividend Yield is rather good when compared to the industry average which is at 2.25. EXPO pays more dividend than 80.25% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 2.34, EXPO is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.7%

5.2 History

The dividend of EXPO is nicely growing with an annual growth rate of 28.57%!
EXPO has paid a dividend for at least 10 years, which is a reliable track record.
EXPO has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)28.57%
Div Incr Years11
Div Non Decr Years11
EXPO Yearly Dividends per shareEXPO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

EXPO pays out 58.36% of its income as dividend. This is a bit on the high side, but may be sustainable.
EXPO's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP58.36%
EPS Next 2Y1.79%
EPS Next 3Y3.43%
EXPO Yearly Income VS Free CF VS DividendEXPO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
EXPO Dividend Payout.EXPO Dividend Payout, showing the Payout Ratio.EXPO Dividend Payout.PayoutRetained Earnings

EXPONENT INC

NASDAQ:EXPO (8/22/2025, 8:05:29 PM)

After market: 72.29 0 (0%)

72.29

+1.81 (+2.57%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)10-22 2025-10-22/amc
Inst Owners95.7%
Inst Owner Change3.31%
Ins Owners0.94%
Ins Owner Change1.69%
Market Cap3.65B
Analysts77.78
Price Target89.76 (24.17%)
Short Float %4.3%
Short Ratio6.51
Dividend
Industry RankSector Rank
Dividend Yield 1.7%
Yearly Dividend1.07
Dividend Growth(5Y)28.57%
DP58.36%
Div Incr Years11
Div Non Decr Years11
Ex-Date09-05 2025-09-05 (0.3)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.77%
Min EPS beat(2)3.34%
Max EPS beat(2)6.21%
EPS beat(4)4
Avg EPS beat(4)5.87%
Min EPS beat(4)2.12%
Max EPS beat(4)11.81%
EPS beat(8)6
Avg EPS beat(8)5.81%
EPS beat(12)8
Avg EPS beat(12)5.15%
EPS beat(16)12
Avg EPS beat(16)6.06%
Revenue beat(2)1
Avg Revenue beat(2)-0.18%
Min Revenue beat(2)-0.43%
Max Revenue beat(2)0.08%
Revenue beat(4)2
Avg Revenue beat(4)-0.35%
Min Revenue beat(4)-2.41%
Max Revenue beat(4)1.35%
Revenue beat(8)4
Avg Revenue beat(8)0.24%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.35%
PT rev (3m)-4.35%
EPS NQ rev (1m)0.66%
EPS NQ rev (3m)1.33%
EPS NY rev (1m)0.68%
EPS NY rev (3m)0.68%
Revenue NQ rev (1m)-1.28%
Revenue NQ rev (3m)-1.72%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.08%
Valuation
Industry RankSector Rank
PE 36.15
Fwd PE 32.91
P/S 6.51
P/FCF 30.19
P/OCF 28.24
P/B 8.53
P/tB 8.71
EV/EBITDA 27.44
EPS(TTM)2
EY2.77%
EPS(NY)2.2
Fwd EY3.04%
FCF(TTM)2.39
FCFY3.31%
OCF(TTM)2.56
OCFY3.54%
SpS11.1
BVpS8.47
TBVpS8.3
PEG (NY)N/A
PEG (5Y)5.36
Profitability
Industry RankSector Rank
ROA 13.54%
ROE 24.04%
ROCE 18.37%
ROIC 13.57%
ROICexc 21.59%
ROICexgc 22.07%
OM 20.46%
PM (TTM) 18.35%
GM 92.62%
FCFM 21.57%
ROA(3y)15.66%
ROA(5y)15.2%
ROE(3y)28.66%
ROE(5y)26.61%
ROIC(3y)18.56%
ROIC(5y)16.83%
ROICexc(3y)30.54%
ROICexc(5y)30.82%
ROICexgc(3y)31.45%
ROICexgc(5y)31.86%
ROCE(3y)25.12%
ROCE(5y)22.78%
ROICexcg growth 3Y-10.75%
ROICexcg growth 5Y-4.18%
ROICexc growth 3Y-10.36%
ROICexc growth 5Y-3.84%
OM growth 3Y-2.87%
OM growth 5Y0.97%
PM growth 3Y-3.48%
PM growth 5Y-0.25%
GM growth 3Y-0.15%
GM growth 5Y-0.21%
F-Score6
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 84.31%
Cap/Sales 1.49%
Interest Coverage 250
Cash Conversion 103.74%
Profit Quality 117.59%
Current Ratio 3.15
Quick Ratio 3.15
Altman-Z 9.49
F-Score6
WACC8.9%
ROIC/WACC1.53
Cap/Depr(3y)141.73%
Cap/Depr(5y)120.6%
Cap/Sales(3y)2.21%
Cap/Sales(5y)1.87%
Profit Quality(3y)105.59%
Profit Quality(5y)110.44%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.44%
EPS 3Y3.72%
EPS 5Y6.74%
EPS Q2Q%-8.77%
EPS Next Y-4.74%
EPS Next 2Y1.79%
EPS Next 3Y3.43%
EPS Next 5YN/A
Revenue 1Y (TTM)3.47%
Revenue growth 3Y6.2%
Revenue growth 5Y6.01%
Sales Q2Q%0.33%
Revenue Next Year3.1%
Revenue Next 2Y5.27%
Revenue Next 3Y5.51%
Revenue Next 5YN/A
EBIT growth 1Y-3.43%
EBIT growth 3Y3.15%
EBIT growth 5Y7.03%
EBIT Next Year27.12%
EBIT Next 3Y12.22%
EBIT Next 5YN/A
FCF growth 1Y39.65%
FCF growth 3Y5.33%
FCF growth 5Y10.11%
OCF growth 1Y24.49%
OCF growth 3Y5.08%
OCF growth 5Y5.99%